Taken together, our findings suggest that palovarotene stimulates the Stat3 signaling pathway and that the Stat3 pathway may underlie the antitumor action of palovarotene on osteochondromas, as this pathway is involved in cartilage degeneration in osteoarthritis. Here, STAT3 is linked to osteoarthritis.